Immediate Impact
24 standout
Citing Papers
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
2025 Standout
Works of Fitalew Tadele Admasu being referenced
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Fitalew Tadele Admasu | 35 | 59 | 30 | 151 | 86 | 33 | 427 | |
| Sue Yee Tan | 9 | 28 | 36 | 123 | 93 | 20 | 477 | |
| Tianli Wang | 7 | 66 | 76 | 92 | 53 | 27 | 445 | |
| Yanyan Wu | 40 | 17 | 49 | 47 | 175 | 14 | 436 | |
| Weijia Sun | 13 | 20 | 26 | 62 | 97 | 34 | 499 | |
| Alberto Maria Pujia | 47 | 39 | 20 | 36 | 68 | 29 | 442 | |
| Zhengwei Wan | 9 | 76 | 111 | 99 | 87 | 38 | 439 | |
| Meisam Akhlaghdoust | 5 | 72 | 34 | 35 | 37 | 41 | 435 | |
| Minyi Zhang | 15 | 93 | 89 | 26 | 100 | 48 | 501 | |
| Jianmei Tian | 22 | 60 | 139 | 41 | 88 | 41 | 428 | |
| Lei Zhu | 2 | 51 | 39 | 113 | 66 | 37 | 499 |
All Works
Login with ORCID to disown or claim papers
Loading papers...